Leif E Lovblom

7PUBLICATIONS
11CO-AUTHORS
Nutrigenomics and personalised nutritionLife historiesCardiology (incl. cardiovascular diseases)Genome structure and regulationPacific Peoples cultural determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 16, 2023
Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonists.

Ronald M Goldenberg, Jeremy D Gilbert, Priya Manjoo

|Dec 08, 2018
Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Julie A Lovshin, Yuliya Lytvyn, Leif E Lovblom

|Oct 03, 2018
Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Julie A Lovshin, Petter Bjornstad, Leif E Lovblom

|Feb 14, 2018
Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Petter Bjornstad, Julie A Lovshin, Yuliya Lytvyn

|Nov 10, 2017
Diabetes Care Disparities in Long-standing Type 1 Diabetes in Canada and the U.S.: A Cross-sectional Comparison.

Alanna Weisman, Leif E Lovblom, Hillary A Keenan

|Oct 25, 2017
Response to Comment on Lovshin et al. Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α1-67 in Patients With Type 2 Diabetes. Diabetes Care 2017;40:1073-1081.

Julie A Lovshin, Leif E Lovblom, David Z I Cherney

Pageof 2

Frequent Collaborators

5 joint publications

David Z I Cherney

4 joint publications

Vera Bril

4 joint publications

Bruce A Perkins

3 joint publications

Hillary A Keenan